If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Result of AGM

25 May 2012 11:26

RNS Number : 1252E
Cathay International Holdings Ld
25 May 2012
 



 

CATHAY INTERNATIONAL HOLDINGS LTD

 

("Cathay" or the "Company")

 

Results of Annual General Meeting

 

 

Hong Kong, 25 May 2012 - Cathay International Holdings Ltd. (LSE: CTI.L), an investment holding company and a leading investor in the growing healthcare sector in the People's Republic of China ("PRC"), today announces that at the Annual General Meeting held earlier today all resolutions were duly passed on poll.

 

Copies of all special resolutions have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.hemscott.com/nsm.do.

 

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director)

Patrick Sung (Director and Controller)

 

Tel: +852 2828 9289

 

M:Communications

Mary-Jane Elliott / Amber Bielecka / Claire Dickinson

 

 

Tel: +44 (0) 20 7920 2330

 

 

About Cathay

Cathay International Holdings Limited (CTI.L) is an investment holding company and a leading investor in the growing healthcare sector in the People's Republic of China ("PRC").

 

Taking advantage of the strong and growing domestic demand for high quality healthcare products in China, Cathay aims to identify investment opportunities with emphasis on high growth healthcare markets and build them into market sector leaders, with a clear exit strategy. Cathay has already demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen Group, China's leading specialty pharmaceutical company focused on rheumatology and Haotian Group, a company engaged in the manufacture, marketing and sale of key active ingredients for healthcare products, including dietary supplement inositol. To complement its healthcare portfolio, Cathay has a research and product development business focused on bringing new products to the growing Chinese market.

 

The Group employs more than 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a private equity investment arm focused on minority investment opportunities and a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGAAMMTMBTTBAT
Date   Source Headline
1st Dec 20205:39 pmRNSCompulsory Acquisition Notice
11th Nov 20209:46 amRNSResults of the Tender Offer
3rd Nov 202010:53 amRNSResult of SGM and Notification of change to Shares
3rd Nov 202010:08 amRNSLansen's seventh share reduction plan of Starry
2nd Nov 202010:11 amRNSDisposal of Starry Shares
29th Oct 202010:43 amRNSTotal Voting Rights
16th Oct 20206:16 pmRNSTender Offer and Notice of SGM
29th Sep 20201:14 pmRNSRequisition Notice
22nd Sep 202010:41 amRNSResults of Annual General Meeting
28th Aug 202012:10 pmRNSInterim Results
28th Aug 202011:57 amRNSNotice of AGM
27th Aug 20202:33 pmRNSLansen's Interim Results
21st Aug 202011:06 amRNSSecond Price Monitoring Extn
21st Aug 202011:00 amRNSPrice Monitoring Extension
14th Aug 20207:00 amRNSNotice of Interim Results 2020
3rd Aug 202011:21 amRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Jul 20209:50 amRNSDisposal of Starry Shares
22nd Jul 202011:46 amRNSDisposal of Starry Shares
17th Jul 202012:12 pmRNSDisposal of Starry Shares
14th Jul 202010:09 amRNSTRANSFER OF LISTING
13th Jul 202011:17 amRNSPoll results of Lansen’s EGM
24th Jun 202010:46 amRNSDespatch of Circular by Lansen
15th Jun 202010:32 amRNSResult of General Meeting (“GM”)
5th Jun 20209:52 amRNSLansen update re Proposed Disposal
29th May 20202:18 pmRNSTotal Voting Rights
28th May 20202:49 pmRNSProposed transfer of listing and Notice of GM
21st May 20202:44 pmRNSTR-1: Notification of major holdings
20th May 20205:20 pmRNSTR-1: Notification of major holdings
18th May 20201:34 pmRNSDirector/PDMR Shareholding
24th Apr 20201:02 pmRNSPublication of Prospectus
21st Apr 20209:07 amRNSPublication and posting of Annual Report
9th Apr 202010:51 amRNSLansen's sixth share reduction plan of Starry
1st Apr 202010:39 amRNSAnnual Results for the year ended 31 December 2019
31st Mar 20202:37 pmRNSLansen reports annual results year ended 31 Dec 19
18th Mar 20207:00 amRNSNotice of Results
28th Feb 20207:00 amRNSTotal Voting Rights
11th Feb 20202:36 pmRNSTrading Update
3rd Feb 20207:00 amRNSBlock listing Six Monthly Return
30th Jan 20207:00 amRNSTreasury Shares,Share Capital,Total Voting Rights
27th Dec 20199:19 amRNSIncrease in shareholder loan
20th Dec 201911:36 amRNSUpdate re Board of Directors
12th Dec 201911:29 amRNSDisposal of Starry Shares
22nd Nov 201911:31 amRNSNew shareholder loan
31st Oct 20199:57 amRNSRetirement of an Executive Director
31st Oct 20197:12 amRNSTotal Voting Rights
30th Sep 20197:00 amRNSTotal Voting Rights
25th Sep 201910:36 amRNSDisposal of Starry Shares
18th Sep 201912:10 pmRNSDisposal of Starry Shares
11th Sep 201911:37 amRNSLansen's fifth share reduction plan of Starry
10th Sep 20193:10 pmRNSDisposal of Starry Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.